BioCentury | Sep 15, 2017
Company News

Wuxi gains commercialization rights to Tozaride in China from Andarix

...Somerville, Mass.) granted Wuxi Fortune Pharmaceutical Co. Ltd. (Wuxi, China) commercialization rights in China for Tozaride...
...and other cancers." Andarix said the companies will collaborate on clinical development of the compound. Tozaride...
...cancer and small cell lung cancer (SCLC). Andarix declined to disclose financial details but said Tozaride...
BioCentury | Aug 11, 2014
Clinical News

Tozaride regulatory update

...Andarix said FDA granted Orphan Drug designation to Tozaride to treat pancreatic cancer. The radiolabeled somatostatin...
...for when the trials are slated to start. Andarix Pharmaceuticals Inc. , Somerville, Mass. Product: Tozaride...
BioCentury | Sep 7, 1999
Finance

Just a little off the top, please

After jacking up as high as $19 intraday on Friday, CV Therapeutics (CVTX) finally slipped $1.375 to $18.125 on 483,300 shares on Friday on news of its plans to float a 4 million share follow-on,...
Items per page:
1 - 3 of 3